Active Ingredient: ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE
Proprietary Name: SEMPREX-D
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 8MG;60MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N019806
Product Number: 001
Approval Date: Mar 25, 1994
Applicant Holder Full Name: ENDO OPERATIONS LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information